JPRN-UMIN000006629已完成1 期
Phase I/II study of peptide pulsed dendritic cell vaccination combined with carboplatin and paclitaxel for patients with advanced malignant melanoma - Phase I/II study of peptide pulsed dendritic cell vaccination combined with carboplatin and paclitaxel for patients with advanced malignant melanoma (DC7)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have active other primary malignancies 2)Patients who have past history of severe allergy 3)Patients who have severe comorbidity (infections, interstitial pneumonia, fibroid lung, cardiovascular disease, renal disease, liver disease, uncontrolled diabetes) 4)Patients who have pleural effusion or pericardial fluid requiring treatment 5)Patients who are pregnant or nursing 6)Male hope to impregnate 7)Carrier of HBV, HCV, HTLV-1, HIV and so on 8)Patients who have severe psychiatric disease 9)Patients who have past history of autoimmune disease 10)During treatment with immunosuppressive agents 11)During treatment with Disulfiram, Cyanamide, carmofur or Procarbazine Hydrochloride 12)Patients who are judged inappropriate to be enrolled in this study by the doctor in charge.
研究者
相似试验
已完成
不适用
Clinical safety of peptide pulsed dendritic cell vaccine after radiofrequency ablation for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000020811Kanazawa University10
招募中
不适用
Exploratory study of WT-1 pulsed dendritic cell immunotherapy as a 2nd line treatment for patients with advanced/recurrent thymic carcinoma.Thymic carcinomaJPRN-UMIN000023543Fukushima Medical University25
招募中
1 期
WT1 peptide-pulsed dendritic cell therapy for wet age-related macular degeneratiowet age-related macular degenerationJPRN-jRCTc030210068Gunji Hisato10
招募中
1 期
A phase 1 clinical trial of peptide-pulsed monocyte-derived dendritic cell vaccination to expand adoptively transferred cytomegalovirus -specific cytotoxic T lymphocytes after allogeneic stem cell transplantatioCytomegalovirus (CMV) reactivation and diseaseBlood - Haematological diseasesInfection - Other infectious diseasesACTRN12608000458336Western Sydney Local Health District18
已完成
不适用
Phase I trial of CHP-HER2-pulsed dendritic cell vaccine for advanced breast and non-small cell lung cancerbreast cancer, non-small cell lung cancerJPRN-UMIN000001295Hokkaido University Hospital, Kyushu University Hospital at Beppu9